No Data
No Data
Are Investors Undervaluing Bluestar Adisseo Company (SHSE:600299) By 30%?
Key Insights The projected fair value for Bluestar Adisseo is CN¥14.44 based on 2 Stage Free Cash Flow to Equity Bluestar Adisseo is estimated to be 30% undervalued based on current share price of
Bluestar Adisseo's half-year performance is expected to increase in 2024 according to the announcement.
Bluestar Adisseo Company's (SHSE:600299) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Most readers would already be aware that Bluestar Adisseo's (SHSE:600299) stock increased significantly by 16% over the past three months. However, we wonder if the company's inconsistent financials
Andisu (600299.SH): Continuing to strengthen collaboration in synthetic biology research
Gelonghui, May 9丨Andy Su (600299.SH) said on an interactive platform that speeding up the development of the specialty products business is one of the keys to the “double pillar” strategy. By optimizing the layout of specialty products on a global scale, the company enhances the cost competitiveness, supply flexibility, customer response speed and level of sustainable development of specialty product supply. Every year, the company invests a large amount of R&D funds in the field of specialty products to ensure the launch of new specialty products and related services through various methods such as internal innovation and external strategic cooperation, while further developing and strengthening marketing products and services. Since 2014, the company has
There May Be Some Bright Spots In Bluestar Adisseo's (SHSE:600299) Earnings
Shareholders appeared unconcerned with Bluestar Adisseo Company's (SHSE:600299) lackluster earnings report last week. We did some digging, and we believe the earnings are stronger than they seem.
Investors in Bluestar Adisseo (SHSE:600299) Have Unfortunately Lost 32% Over the Last Five Years
Bluestar Adisseo Company (SHSE:600299) shareholders should be happy to see the share price up 12% in the last quarter. But over the last half decade, the stock has not performed well. You would ha
No Data